Boston Immune Technologies & Therapeutics
Pre-clinicalBoston Immune develops novel immunotherapies targeting immune checkpoints for cancer and autoimmune diseases.
Founded
2017
Focus
AntibodiesBiologics
About
Boston Immune develops novel immunotherapies targeting immune checkpoints for cancer and autoimmune diseases.
Funding History
2Total raised: $17M
Series A$12MAgent CapitalMar 15, 2021
Seed$5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2017
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile